Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06071104 · ClinicalTrials.gov registry record · NA
Next Generation Cataract Surgery Study
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT06071104: Completed NA study, sponsored by Alcon Research.
NCT06071104 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 121 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06071104, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain device-specific safety and performance clinical data to support marketability in Europe and to collect user preference data.
Primary Outcome
As recorded by the surgeon on a user questionnaire based on Day 0 surgery experience. From Protocol Section 5.1, the intended use for UNITY VCS is to facilitate management of fluid as well as removal, cutting, and coagulation of ocular materials. One eye (study eye) contributed data to the analysis. No hypothesis testing was pre-specified for this endpoint.
Interventions
- PROCEDURE Anterior segment ophthalmic surgery
- DEVICE UNITY VCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2023-12-06 |
| Est. Completion | 2024-06-28 |
| Phase | NA |
What the finished NCT06071104 record still lists
NCT06071104 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Anterior segment ophthalmic surgery is the first listed.
NCT06071104 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06071104 about?
NCT06071104 is a clinical study titled "Next Generation Cataract Surgery Study". The purpose of this study is to obtain device-specific safety and performance clinical data to support marketability in Europe and to collect user preference data.
What is the current status of trial NCT06071104?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2023-12-06. Estimated completion is 2024-06-28.
What interventions are being tested in trial NCT06071104?
The interventions under investigation include: Anterior segment ophthalmic surgery (PROCEDURE), UNITY VCS (DEVICE).
Who is sponsoring clinical trial NCT06071104?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06071104's enrollment target sits among peer trials
121 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI